In continuation to our letter dated February 22, 2026, we hereby inform you that GST inspection, search and seizure operation at the registered office of the Company which commenced on February 21, 2026 has concluded on February 25, 2026.
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Updates On GST Inspection, Search And Seizure
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Feb 22 2026
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - GST Inspection, Search And Seizure
- Sudarshan Pharma Industries Ltd Press Release Feb 09 2026
- Clarification On Price Movement - Company Reply
- Sudarshan Pharma Industries Ltd Press Release Jan 31 2026
Later from Sudarshan Pharma Industries
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Mar 30 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Sudarshan Pharma Industries Ltd Press Release Apr 06 2026
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries